Clinical Trial Update: GPR119 Agonist for Hypoglycemia in Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an investigational GPR119 agonist for managing hypoglycemia in Type 1 diabetes has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GPR119 agonist (investigational) (GPR119 agonist)

Snippet

Sponsor: AdventHealth Translational Research Institute | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2024-10-17